LARS2 and neoplasm: These molecular alterations suggest that LARS2 and SEZ6L2 might contribute to COAD progression by promoting tumor growth and immune evasion, whereas SOX7 downregulation may facilitate tumor development by impairing tumor suppressive pathways.